（7种）蒽环类相关化合物在阿霉素敏感的人小细胞肺癌细胞系及其阿霉素耐药后代中的活性。阿霉素、柔红霉素、4-脱氧柔红霉素、4-去甲氧基柔红霉素、地托比星、4'-表阿霉素和米托蒽醌的活性。 - Suppr | 超能文献

Activity of (7) anthracycline related compounds in an doxorubicin sensitive human small cell lung cancer line and its doxorubicin resistant descendant. Activity of doxorubicin, daunorubicin, 4-deoxyrubicin, 4-demethoxydaunorubicin, detorubicin, 4'-epidoxorubicin and mitoxantrone.

作者信息

Zijlstra J G, Meijer C, Timmer-Bosscha H, Le T K, de Vries E G, Mulder N H

出版信息

Eur J Respir Dis Suppl. 1987;149:53-5.

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Activity of (7) anthracycline related compounds in an doxorubicin sensitive human small cell lung cancer line and its doxorubicin resistant descendant. Activity of doxorubicin, daunorubicin, 4-deoxyrubicin, 4-demethoxydaunorubicin, detorubicin, 4'-epidoxorubicin and mitoxantrone.（7种）蒽环类相关化合物在阿霉素敏感的人小细胞肺癌细胞系及其阿霉素耐药后代中的活性。阿霉素、柔红霉素、4-脱氧柔红霉素、4-去甲氧基柔红霉素、地托比星、4'-表阿霉素和米托蒽醌的活性。

Eur J Respir Dis Suppl. 1987;149:53-5.

2

[Establishment of adriamycin-resistant human small-cell lung cancer cells in culture: analysis of the mechanism of resistance and cross-resistance].[培养阿霉素耐药人小细胞肺癌细胞：耐药及交叉耐药机制分析]

Gan To Kagaku Ryoho. 1987 Mar;14(3 Pt 2):830-6.

3

Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.基于耐药细胞系基因表达谱预测乳腺癌中多柔比星敏感性与患者生存率相关。

Oncogene. 2005 Nov 17;24(51):7542-51. doi: 10.1038/sj.onc.1208908.

4

[14-O-hemiesters and 13-hydrazones of anthracyline antibiotics of the daunorubicin series. Synthesis and cytostatic activity with respect to tumor cells sensitive or resistant to doxorubicin].[柔红霉素系列蒽环类抗生素的14 - O - 半酯和13 - 腙。对阿霉素敏感或耐药肿瘤细胞的合成及细胞抑制活性]

Bioorg Khim. 1995 Dec;21(12):925-32.

5

Properties of antitumor anthracyclines and new developments in their application: Cain memorial award lecture.抗肿瘤蒽环类药物的特性及其应用的新进展：该隐纪念奖讲座

Cancer Res. 1985 Dec;45(12 Pt 1):5995-9.

6

Quantitative models for growth inhibition of human leukemia cells by antitumor anthracycline derivatives.抗肿瘤蒽环类衍生物对人白血病细胞生长抑制的定量模型

Cancer Res. 1979 Sep;39(9):3661-72.

7

In vitro studies on anthracycline haloderivatives.蒽环类卤代衍生物的体外研究。

Drugs Exp Clin Res. 1986;12(8):657-61.

8

Cross-resistance of menogaril and mitoxantrone in a subline of P388 leukemia resistant to doxorubicin.

Cancer Treat Rep. 1987 Feb;71(2):195-6.

9

Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.蒽环类药物及相关合成衍生物构效关系的临床评估

Cancer Treat Rep. 1986 Jan;70(1):51-63.

10

A comparison of in vitro sensitivity of acute myeloid leukemia precursors to mitoxantrone, 4'deoxydoxorubicin, 4-demethoxydaunorubicin and daunorubicin.急性髓系白血病前体细胞对米托蒽醌、4'-脱氧阿霉素、4-去甲氧基柔红霉素和柔红霉素的体外敏感性比较。

Leuk Res. 1986;10(12):1455-9. doi: 10.1016/0145-2126(86)90013-5.

引用本文的文献

1

Clinical pharmacokinetics of idarubicin.伊达比星的临床药代动力学。

Clin Pharmacokinet. 1993 Apr;24(4):275-88. doi: 10.2165/00003088-199324040-00002.

2

Oral idarubicin--an anthracycline derivative with unique properties.口服伊达比星——一种具有独特性质的蒽环类衍生物。

Ann Hematol. 1993 Jan;66(1):33-43. doi: 10.1007/BF01737687.

3

Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.伊达比星。对其药效学和药代动力学特性以及在癌症化疗中的治疗潜力的综述。

Drugs. 1991 Oct;42(4):690-719. doi: 10.2165/00003495-199142040-00010.